Alerts will be sent to your verified email
Verify Email
ZIMLAB
|
Zim Laboratories
|
Kilitch Drugs(India)
|
Anuh Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
R&D as a % of Total Sales
|
7.69 % | n/a | 0.0 |
|
Financials
|
|||
|
5 yr Average ROE
|
6.9 % | 7.31 % | 15.87 % |
|
5yr average Equity Multiplier
|
1.84 | 1.48 | 1.62 |
|
5yr Average Asset Turnover Ratio
|
0.89 | 0.56 | 1.35 |
|
5yr Avg Net Profit Margin
|
3.99 % | 8.44 % | 7.23 % |
|
Price to Book
|
2.24 | 2.3 | 2.23 |
|
P/E
|
113.6 | 21.31 | 19.14 |
|
5yr Avg Cash Conversion Cycle
|
35.94 Days | 14.76 Days | 42.81 Days |
|
Inventory Days
|
73.14 Days | 14.42 Days | 50.87 Days |
|
Days Receivable
|
105.27 Days | 136.16 Days | 111.12 Days |
|
Days Payable
|
144.59 Days | 212.73 Days | 117.6 Days |
|
5yr Average Interest Coverage Ratio
|
3.9 | 6.02 | 48.66 |
|
5yr Avg ROCE
|
11.83 % | 11.26 % | 21.17 % |
|
5yr Avg Operating Profit Margin
|
11.23 % | 12.28 % | 10.21 % |
|
5 yr average Debt to Equity
|
0.38 | 0.17 | 0.02 |
|
5yr CAGR Net Profit
|
-16.69 % | 48.72 % | 10.73 % |
|
5yr Average Return on Assets
|
3.78 % | 4.99 % | 9.84 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
30.35 % | 63.77 % | 71.8 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-2.91 % | -4.48 % | 1.21 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Zim Laboratories
|
Kilitch Drugs(India)
|
Anuh Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Capex
|
Capex
|
-
|
-
|
|
Customer Segment
|
Customer Segment
|
-
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|